Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Investment Banking Fees To Aid JPMorgan's (JPM) Q4 Earnings

Published 01/12/2020, 09:07 PM
Updated 07/09/2023, 06:31 AM

The performance of investment banking (IB), one of the major sources of revenues for JPMorgan (NYSE:JPM) , is likely to have been decent in fourth-quarter 2019. Thus, this will support the bank’s results to some extent, scheduled to be announced on Jan 14.

Investment banking income basically comprises advisory fees (generated from M&A deals and IPOs) and underwriting revenues (equity and debt). So, let’s check how these are likely to have been in the to-be-reported quarter.

Low interest rates and gradual easing of geopolitical concerns are expected to have offered support to IB fees. Though the number of closed deals declined during the fourth quarter, a higher number of announced M&As indicate a strong pipeline. Further, global deal value declined as well. Thus, this likely had an adverse impact on JPMorgan’s advisory fees. However, the bank’s leadership in the space is likely to have provided some leverage.

Solid equity markets performance and the central banks’ accommodative stance drove corporates to issue equities across the globe. Likewise, IPO activities witnessed an uptrend during the to-be-reported quarter. Moreover, bond issuance volumes were strong while debt issuances were muted as loan demand was soft.

Therefore, growth in JPMorgan’s equity underwriting fees and debt origination fees (accounting for almost 60% of total investment banking fees) is expected to have remained soft in the fourth quarter.

Further, management expects IB revenues to be flat on a year-over-year basis. In the December investor conference, JPMorgan’s CFO Jennifer Piepszak said, “The quarter has played out a little bit better than we thought largely on healthy investment grade flow given the rate environment. Important to note there that the wallet is shrinking. So staying flat for us year-over-year is the continuation of us taking share in IB fees.”

The Zacks Consensus Estimate for IB fees of $1.81 billion indicates a slight fall from the prior-year quarter reported number.

Overall Earnings & Revenue Projections

For JPMorgan, the Zacks Consensus Estimate for earnings of $2.32 indicates 17.2% growth on a year-over-year basis. However, the consensus estimate for sales of $27.3 billion indicates 4.4% rise.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

JPMorgan Chase & Co. Price and EPS Surprise

JPMorgan Chase & Co. price-eps-surprise | JPMorgan Chase & Co. Quote

Click here to know about the other factors that are likely to influence the bank’s overall results.

Our Viewpoint

Amid lower interest rates and soft corporate lending, somewhat decent IB performance is likely to have had a positive effect on JPMorgan’s top-line growth. Solid mortgage banking and strong trading activities are likely to have offered some support.

Currently, JPMorgan carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

IB Performance Expectations for Other Banks

Among the other companies, trading revenues are a major portion of total revenues for Bank of America (NYSE:BAC) , Goldman Sachs (NYSE:GS) and Morgan Stanley (NYSE:MS) . Similar to JPMorgan, IB performance is likely to have supported these banks’ revenues and earnings in the fourth quarter.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



JPMorgan Chase & Co. (JPM): Free Stock Analysis Report

Bank of America Corporation (BAC): Free Stock Analysis Report

The Goldman Sachs Group, Inc. (GS): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Morgan Stanley (MS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.